A multi-center, forward-looking and observational study on the safety and effectiveness of Iodixanol Injection in enhanced CT examination

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000040595

Enrollment

Unknown

Registered

2020-12-03

Start date

2020-12-02

Completion date

Unknown

Last updated

2021-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CT enhanced examination

Interventions

Case series:none

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) Aged >=18 years old; (2) Inpatients undergoing enhanced CT examination with Iodixanol Injection; (3) Have serum creatinine test within 7 days before enrollment; (4) Willing to sign an informed consent.

Exclusion criteria

Exclusion criteria: (1) Patients with hyperthyroidism with uncontrolled symptoms; (2) Patients with a history of allergies to iodine-containing substances; (3) Acute attack of allergic diseases; (4) Pregnant women; (5) Outpatient.

Design outcomes

Primary

Measure	Time frame
Incidence of adverse reactions ;CI-AKI;	—

Secondary

Measure	Time frame
imaging quality;	—

Countries

China

Contacts

Public ContactMin Chen

Beijing Hospital

cjr.chenmin@vip.163.com+86 010-85133804

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026